Suchergebnisse - "Catechol O-Methyltransferase Inhibitors"

PubPharm (1.109)

1

Objective assessment of the effects of opicapone in Parkinson's disease through kinematic analysis

enthalten in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology | 2024

von Bologna, M. | Guerra, A. | Colella, D. | +8

ErratumIn: Neurol Sci. 2023 Dec 28;:. - PMID 38153679

2

Effectiveness and safety of different catechol-o-methyl transferase inhibitors for patients with parkinson's disease : Systematic review and network meta-analysis

enthalten in: Clinical neurology and neurosurgery | 2024

von Wu, W. | Lu, X. | Zhang, L. | +1

3

Inhibition of catechol-O-methyltransferase (COMT) by heparin oligosaccharides with specific structures

enthalten in: Carbohydrate polymers | 2024

von Chen, Q. | Wang, Q. | Bu, C. | +3

4

A systematic review of the cognitive effects of the COMT inhibitor, tolcapone, in adult humans

enthalten in: CNS spectrums | 2024

von Kings, E. | Ioannidis, K. | Grant, J. | +1

5

Advanced Parkinson's disease treatment patterns in Italy : an observational study interim analysis

enthalten in: Annals of medicine | 2024

von Stocchi, F. | Barone, P. | Ceravolo, R. | +7

6

HR/MS-based lipidome analysis of rat brain modulated by tolcapone

enthalten in: Journal of pharmaceutical and biomedical analysis | 2024

von Rebouta, J. | Dória, L. | Coelho, A. | +5

7

A 12-month prospective real-life study of opicapone efficacy and tolerability in Emirati and non-White subjects with Parkinson's disease based in United Arab Emirates

enthalten in: Journal of neural transmission (Vienna, Austria : 1996) | 2024

von Metta, V. | Ibrahim, H. | Muralidharan, N. | +14

8

Catechol-O-Methyltransferase inhibition and alcohol use disorder : Evaluating the efficacy of tolcapone in ethanol-dependent rats

enthalten in: Neuropharmacology | 2024

von Doyle, M. | Dirik, S. | Martinez, A. | +6

9

Opicapone versus entacapone : Head-to-head retrospective data-based comparison of healthcare resource utilization in people with Parkinson's disease new to catechol-O-methyltransferase (COMT) inhibitor treatment

enthalten in: European journal of neurology | 2023

von Harrison-Jones, G. | Marston, X. | Morgante, F. | +3

10

Synthesis and characterization of chemical engineered PLGA nanosphere : Triggering mechanism of Catechol-O-methyltransferase inhibition on in vivo neurodegeneration

enthalten in: Bioorganic chemistry | 2023

von Poonkuzhali, K. | Seenivasagan, R. | Prabhakaran, J. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[111]